PAHC or LMAT: Which Is the Better Value Stock Right Now?

In a comparison of two Medical-Products sector stocks, Phibro Animal Health (PAHC) emerges as the superior value investment option compared to LeMaitre Vascular (LMAT). PAHC holds a Zacks Rank of #2 (Buy) with a Value grade of A, featuring a forward P/E of 11.20 and PEG ratio of 1.13. LMAT, rated #4 (Sell) with a Value grade of D, has a forward P/E of 28.10 and PEG ratio of 2.34, indicating it is relatively overvalued.